New Medicaid drug-pricing model could improve access to asthma and allergy medications
Although the program has potential to improve access, CMS has not yet published a list of participating drugs or announced the coverage requirements.
Get 2027 coding books at discounted prices
We’ve partnered with OPTUM360 for special discounted pricing on some of the most popular coding books.
Medicare contractors finalize new allergy diagnostic testing LCDs
The Advocacy Council submitted detailed comments on the proposed LCDs during the public comment period earlier this year.
College leaders advocate for allergists and patients on Capitol Hill
Strike Force members spent three days on Capitol Hill meeting with members or legislative assistants in more than 25 Congressional offices.
AMA and MGMA back allergists’ call for an applicable MIPS Value Pathway
In the CMS 2027 Proposed QPP Rule, CMS proposed retiring the traditional MIPS reporting option after the 2028 performance period.
Allergists are off to Washington again
This week, a group of allergists will meet in Washington D.C. for the College’s 2026 Advocacy “Strike Force 2.0” on Capitol Hill.
ACAAI urges CMS to protect allergy practices
Medicare policy must reflect how allergy care is actually delivered and must not create new barriers for small and independent practices.
Making the case for fair allergy immunotherapy policy
The comment period for the proposed 2027 Medicare Physician Fee Schedule closed Sept. 14, and ACAAI made sure the voice of allergy was heard.
UHC touts prior authorization relief
A careful review of the codes finds little that will reduce the everyday administrative burden faced by allergists.
Medicare Advantage appeals process explained
To effectively advocate for their patients and to secure appropriate reimbursement, clinicians must understand the MA appeals framework.
… results in College Insider and Advocacy Resources.
